Register for updates

 
 

Medicine & Health
RSS Feed
New Antibacterial Fillings from TAU May Combat Recurring Tooth Decay
Tuesday, July 09, 2019 9:00:00 AM

Novel material may prevent one of the costliest and most prevalent bacterial diseases in the world

Tooth decay is among the costliest and most widespread bacterial diseases. Virulent bacteria cause the acidification of tooth enamel and dentin, which, in turn, causes secondary tooth decay.

A new study by Tel Aviv University researchers finds potent antibacterial capabilities in novel dental restoratives, or filling materials. According to the research, the resin-based composites, with the addition of antibacterial nano-assemblies, can hinder bacterial growth and viability on dental restorations, the main cause of recurrent cavities, which can eventually lead to root canal treatment and tooth extractions.

Research for the study was led by Dr. Lihi Adler-Abramovich and TAU doctoral student Lee Schnaider in collaboration with Prof. Ehud Gazit, Prof. Rafi Pilo, Prof. Tamar Brosh, Dr. Rachel Sarig and colleagues from TAU's Maurice and Gabriela Goldschleger School of Dental Medicine and George S. Wise Faculty of Life Sciences. It was published in ACS Applied Materials & Interfaces on May 28.

"Antibiotic resistance is now one of the most pressing healthcare problems facing society, and the development of novel antimicrobial therapeutics and biomedical materials represents an urgent unmet need," says Dr. Adler-Abramovich. "When bacteria accumulate on the tooth surface, they ultimately dissolve the hard tissues of the teeth. Recurrent cavities — also known as secondary tooth decay — at the margins of dental restorations results from acid production by cavity-causing bacteria that reside in the restoration-tooth interface."

This disease is a major causative factor for dental restorative material failure and affects an estimated 100 million patients a year, at an estimated cost of over $30 billion.

Historically, amalgam fillings composed of metal alloys were used for dental restorations and had some antibacterial effect. But due to the alloys' bold color, the potential toxicity of mercury and the lack of adhesion to the tooth, new restorative materials based on composite resins became the preferable choice of treatment. Unfortunately, the lack of an antimicrobial property remained a major drawback to their use.

"We've developed an enhanced material that is not only aesthetically pleasing and mechanically rigid but is also intrinsically antibacterial due to the incorporation of antibacterial nano-assemblies," Schnaider says. "Resin composite fillings that display bacterial inhibitory activity have the potential to substantially hinder the development of this widespread oral disease."

The scientists are the first to discover the potent antibacterial activity of the self-assembling building block Fmoc-pentafluoro-L-phenylalanine, which comprises both functional and structural subparts. Once the researchers established the antibacterial capabilities of this building block, they developed methods for incorporating the nano-assemblies within dental composite restoratives. Finally, they evaluated the antibacterial capabilities of composite restoratives incorporated with nanostructures as well as their biocompatibility, mechanical strength and optical properties.

"This work is a good example of the ways in which biophysical nanoscale characteristics affect the development of an enhanced biomedical material on a much larger scale," Schnaider says.

"The minimal nature of the antibacterial building block, along with its high purity, low cost, ease of embedment within resin-based materials and biocompatibility, allows for the easy scale-up of this approach toward the development of clinically available enhanced antibacterial resin composite restoratives," Dr. Adler-Abramovich says.

The researchers are now evaluating the antibacterial capabilities of additional minimal self-assembling building blocks and developing methods for their incorporation into various biomedical materials, such as wound dressings and tissue scaffolds.




Latest News

Study Reveals Two Writers Penned Landmark Inscriptions in Eighth-Century BCE Samaria

Discovery illuminates bureaucratic apparatus of ancient kingdom of Israel, say TAU researchers.

Siblings of Children With Intellectual Disabilities Score High on Empathy, Teaching and Closeness

TAU research indicates positive relationship between children and their siblings with intellectual disabilities.

Fibroblasts Involved in Healing Spur Tumor Growth in Cancer

Vital to healing wounds, fibroblasts have a "misguided" response to cancer cells, according to TAU researchers.

TAU Study Finds Widespread Misinterpretation of Gene Expression Data

But bias can be removed from data to filter out false results, researchers say.

Made a "Dumb" Move? New Studies Say a Neuronal Mechanism Is to Blame

TAU, Hebrew University research finds a neuronal mechanism explains much of our irrational behavior.

Tiny Insects Become "Visible" to Bats When They Swarm

3-D simulations could provide new insights into the evolution of bat echolocation, TAU researchers say.

AFTAU Earns 4-Star Rating from Charity Navigator for Seventh Consecutive Year

Charity Navigator's highest rating indicates the nonprofit exceeds industry standards and outperforms other organizations.

TAU Partners with Columbia University to Launch Dual Degree Program

Israeli university's first-ever joint undergraduate program with an Ivy League university offers students a world-class liberal arts education on two continents.

TAU’s Prof. Ilan Tsarfaty Awarded Breast Cancer Research Foundation Grant

BCRF granted $66 million in funding to 275 scientists at institutions worldwide in 2019.

TAU's Prof. Carmit Levy Receives Young Investigator Award at Society for Melanoma Research Summit

Researcher honored for major contributions to the field of melanoma research.

contentSecondary
c

© 2020 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University